Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
Status:
Unknown status
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Myelodysplastic syndrome (MDS) is a rare, potentially serious bone marrow disease. Currently
available treatments for MDS have been only somewhat beneficial. The purpose of this study is
to determine the effects of the medication antithymocyte globulin (ATG) in adults with MDS
and to determine which individuals with MDS are most likely to benefit from treatment with
ATG.